Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Specialty Chemicals
Ingevity will acquire Perstorp’s caprolactone business
by Michael McCoy
December 16, 2018
| A version of this story appeared in
Volume 96, Issue 49
Credit: Perstorp
Perstorp produces caprolactone at this facility in Warrington, England.
Ingevity has agreed to acquire Perstorp’s caprolactone business for about $675 million. The business produces caprolactone and its derivatives at a plant in Warrington, England. It has annual sales of about $175 million. Ingevity was formed in 2016 as a chemical spin-off of the papermaker MeadWestvaco. Last year Ingevity acquired Georgia-Pacific’s pine chemical business for $315 million.
Chemical & Engineering News
ISSN 0009-2347
Copyright © 2024 American Chemical Society
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X